PloS one · 2018
Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.
СтатьяПоддержка исследования: вне правительства СШАВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shey Robert Adamu, Ghogomu Stephen Mbigha, Njume Ferdinand Ngale, Gainkam Lea Olive Tchouate, Poelvoorde Philippe, Mutesa Leon, Robert Annie, Humblet Perrine, Munyampundu Jean-Pierre, Kamgno Joseph, Lelubre Christophe, Vanhamme Luc, Souopgui Jacob
Аннотация
Onchocerciasis is a severely debilitating yet neglected tropical disease (NTD) that creates social stigma, generates and perpetuates poverty, and leads ultimately in some cases to irreversible unilateral or bilateral blindness if untreated. Consequently, the disease is a major impediment to socioeconomic development. Many control programs have been launched for the disease with moderate successes achieved. This mitigated hit is partially due to the lingering need for reliable, non-invasive and easily applicable tools for mapping endemic regions and post-elimination surveillance. In this work, bioinformatics analyses combined with immunological assays were applied in a bid to develop potential tools for diagnosis and assessing the success of drug treatment programs. We report that (i) the O. volvulus antigen, Ov58GPCR is a G-protein coupled receptor (GPCR) conserved in related nematodes, (ii) synthetic peptides predicted to be in the extracellular domain (ECD) of Ov58GPCR are indeed immunogenic epitopes in actively-infected individuals, (iii) synthetic peptide cocktails discriminate between actively-infected individuals, treated individuals and healthy African controls, (iv) polyclonal antibodies against one of the peptides or against the bacterially-expressed ECD reacted specifically with the native antigen of O. volvulus total and surface extracts, (v) Ov58GPCR is transcribed in both larvae and adult parasite stages, (vi) IgG and IgE responses to the recombinant ECD decline with ivermectin treatment. All these findings suggest that the extracellular domain and synthetic peptides of Ov58GPCR, as well as the specific immune response generated could be harnessed in the context of disease diagnosis and surveillance.
Предметные рубрики MeSH
AdultAnimalsAntigens, HelminthAntiparasitic AgentsComputational BiologyCross-Sectional StudiesEndemic DiseasesEpidemiological MonitoringEscherichia coliFemaleHumansImmunity, HumoralImmunoglobulin EImmunoglobulin GIvermectinMaleNeglected DiseasesOnchocerca volvulusOnchocerciasisProtein DomainsRecombinant ProteinsYoung Adult